Ken Fisher’s Novavax NVAX Stock Holding History

Ken Fisher’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,212	Closed	-$371K	–	983
2022 Q2	$371K	Sell	7,212 -141	-2%	-$7.3K	﹤0.01%	766
2022 Q1	$542K	Buy	7,353 +5	+0.1%	+$446	﹤0.01%	719
2021 Q4	$1.05M	Buy	7,348 +107	+1%	+$18.4K	﹤0.01%	634
2021 Q3	$1.5M	Buy	7,241 +43	+0.6%	+$9.48K	﹤0.01%	560
2021 Q2	$1.53M	Sell	7,198 -80	-1%	-$14.7K	﹤0.01%	557
2021 Q1	$1.32M	Sell	7,278 -69	-0.9%	-$13.8K	﹤0.01%	576
2020 Q4	$819K	Buy	7,347 +150	+2%	+$15.9K	﹤0.01%	622
2020 Q3	$780K	Hold	7,197	–	–	﹤0.01%	590
2020 Q2	$600K	Buy	+7,197	New	+$275K	﹤0.01%	635
2019 Q2	–	Sell	-7,703	Closed	-$85K	–	856
2019 Q1	$85K	Buy	7,703 +470	+6%	+$14.8K	﹤0.01%	781
2018 Q4	$266K	Buy	7,233 +35	+0.5%	+$1.36K	﹤0.01%	730
2018 Q3	$271K	Hold	7,198	–	–	﹤0.01%	725
2018 Q2	$193K	Hold	7,198	–	–	﹤0.01%	771
2018 Q1	$302K	Hold	7,198	–	–	﹤0.01%	677
2017 Q4	$179K	Buy	+7,198	New	+$176K	﹤0.01%	832

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ken Fisher's NVAX Position: Q3 2022 in Review

Ken Fisher sold out of Novavax (NVAX) in Q3 2022, closing a stake of 7,212 shares — an estimated $371K sold.

Ken Fisher first reported a position in NVAX in Q4 2017 and held it in 15 quarters. The position peaked at $1.53M in Q2 2021. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

Ken Fisher reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
Ken Fisher sold 7,212 Novavax shares in Q3 2022, an estimated $371K.
Ken Fisher first reported a position in Novavax in Q4 2017 and held it in 15 quarters.
Ken Fisher's Novavax position peaked at $1.53M in Q2 2021.
254 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Fisher Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.